Lifshitz & Miller LLP Announces Investigation of Acadia Pharmaceuticals Inc., Allegiant Travel Company, Camping World Holdings, Inc., Finish Line, Inc., Myriad Genetics, Inc., Proteostasis...

NEW YORK, April 24, 2018 /PRNewswire/ -- 

Acadia Pharmaceuticals Inc. (ACAD)

Lifshitz & Miller announces investigation into possible securities law violations in connection with a report that Acadia's drug Nuplazid has been associated with more than 700 deaths.

If you are an Acadia investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at info@jlclasslaw.com.

Allegiant Travel Company (ALGT)

Lifshitz & Miller announces investigation into possible securities law violations in connection with aircraft safety issues and mechanical problems.

If you are an Allegiant investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at info@jlclasslaw.com.

Camping World Holdings, Inc. (CWH)

Lifshitz & Miller announces investigation into possible securities law violations in connection with allegations of material weaknesses in its internal controls over financial reporting.

If you are a Camping World investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at info@jlclasslaw.com.

Finish Line, Inc. (FINL)

Lifshitz & Miller announces investigation into possible possible breaches of fiduciary duties in connection with the proposed sale of Finish Line to JD Sports Fashion PLC., for $13.50 in cash per share.

If you are a Finish Line investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at info@jlclasslaw.com.

Myriad Genetics, Inc. (MYGN)

Lifshitz & Miller announces investigation into possible securities law violations in connection with MYGN's receipt of a subpoena from DHHS regarding possible improper Medicare/Medicaid claims.

If you are a Myriad investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at info@jlclasslaw.com.

Proteostasis Therapeutics, Inc. (PTI)

Lifshitz & Miller announces investigation into possible securities law violations in connection with PTI's statements regarding PTI-428 trials.

If you are a PTI investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at info@jlclasslaw.com.

Under Armour, Inc. (UA)

Lifshitz & Miller announces investigation into possible securities law violations in connection with a data breach affecting millions of users of UA's app, MyFitnessPal.

If you are an Under Armour investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at info@jlclasslaw.com.

United Community Bancorp (UCBA)

Lifshitz & Miller announces investigation into possible breaches of fiduciary duties in connection with the proposed sale of UCBA to Civista Bancshares, Inc., for $2.54 in cash and 1.027 Civista shares per share.

If you are a UCBA investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at info@jlclasslaw.com.

ATTORNEY ADVERTISING. © 2018 Lifshitz & Miller LLP.  The law firm responsible for this advertisement is Lifshitz & Miller LLP, 821 Franklin Avenue, Suite 209, Garden City, New York 11530, Tel: (516)493-9780.  Prior results do not guarantee or predict a similar outcome with respect to any future matter.

Contact:

Joshua M. Lifshitz, Esq.
Lifshitz & Miller LLP
Phone:  516-493-9780
Facsimile: 516-280-7376
Email: info@jlclasslaw.com

View original content:http://www.prnewswire.com/news-releases/lifshitz--miller-llp-announces-investigation-of-acadia-pharmaceuticals-inc-allegiant-travel-company-camping-world-holdings-inc-finish-line-inc-myriad-genetics-inc-proteostasis-therapeutics-inc-under-armour-inc-an-300635564.html

SOURCE Lifshitz & Miller Law Firm